You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 107 No. 11, November 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Auricular Malignant Neoplasms

When Is Chemotherapy (Mohs' Technique) Necessary?

Robert M. Bumsted, MD; Roger I. Ceilley, MD; William R. Panje, MD; Roger L. Crumley, MD

Arch Otolaryngol. 1981;107(11):721-724.


Abstract

• A prospective study of 71 auricular malignant neoplasms was performed to identify lesions with a high risk of recurrence. Previously recommended margins for conventional surgical excision were marked. Then, all lesions were excised by the Mohs' technique. The Mohs' defect was compared with previously marked margins for conventional excision. Conventional excision would have been inadequate in 13% of primary and initially recurrent lesions smaller than 1 cm (clinical examination) and in 27% of primary lesions and 33% of recurrent lesions larger than 1 cm. All cases successfully excised by conventional excision would have resulted in a larger defect than the actual Mohs' defect. Morpheaform basal cell carcinoma was the most common lesion inadequately excised. Either cases of this histologic type or lesions larger than 1 cm or both require consideration for the use of the Mohs' technique.

(Arch Otolaryngol 1981;107:721-724)



Author Affiliations

From the Departments of Otolaryngology and Maxillofacial Surgery (Drs Bumsted and Panje) and Dermatology (Dr Ceilley), University of Iowa Hospitals and Clinics, Iowa City; and the Department of Otolaryngology, University of California, San Francisco (Dr Crumley).


Footnotes

Accepted for publication May 26, 1981.

Read before the combined meeting of the Society of Head and Neck Surgeons and the American Society for Head and Neck Surgery, Phoenix, Ariz, March 11, 1981.

Reprint requests to the Department of Otolaryngology and Maxillofacial Surgery, University of Iowa Hospital and Clinics, Iowa City, IA 52240 (Dr Bumsted).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mohs Surgery: The Informed View
McGovern and Leffell
Arch Dermatol 1999;135:1255-1259.
FULL TEXT  

Prognostic Factors in Carcinoma of the External Auditory Canal
Testa et al.
Arch Otolaryngol Head Neck Surg 1997;123:720-724.
ABSTRACT  

Surgical Margins for Basal Cell Carcinoma
Wolf and Zitelli
Arch Dermatol 1987;123:340-344.
ABSTRACT  

Delayed Skin Grafting in Facial Reconstruction: When to Use and How to Do
Bumsted et al.
Arch Otolaryngol Head Neck Surg 1983;109:178-184.
ABSTRACT  

Auricular Malignant Neoplasms: Identification of High-Risk Lesions and Selection of Method of Reconstruction
Bumsted and Ceilley
Arch Otolaryngol Head Neck Surg 1982;108:225-231.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.